Glutamate transmission and toxicity in Alzheimer's disease
- PMID: 2900537
- DOI: 10.1016/0278-5846(88)90102-9
Glutamate transmission and toxicity in Alzheimer's disease
Abstract
1. Despite intensive research, the cause of Alzheimer's disease is unknown. 2. Glutamate is the major excitatory transmitter of the cerebral cortex and hippocampus and it appears to have an important role in learning and memory. In addition to its transmitter function, glutamate is a neurotoxin which has been implicated in the pathogenesis of a variety of neurodegenerative disorders. 3. Glutamate toxicity may play a role in the pathogenesis of Alzheimer's disease. 4. Disruption of glutamatergic neurotransmission may account, in part, for the learning and memory deficits of Alzheimer's disease. 5. Labeling of the glutamate receptor complex may allow in vivo diagnosis by positron emission tomography. 6. Glutamate receptor ligands may provide a means of therapeutic intervention in Alzheimer's disease.
Similar articles
-
Does modulation of glutamatergic function represent a viable therapeutic strategy in Alzheimer's disease?Biol Psychiatry. 1992 Feb 15;31(4):337-50. doi: 10.1016/0006-3223(92)90227-q. Biol Psychiatry. 1992. PMID: 1348429 Review.
-
Cortical amino acidergic pathways in Alzheimer's disease.J Neural Transm Suppl. 1987;24:147-52. J Neural Transm Suppl. 1987. PMID: 2824688 Review.
-
[Glutaminergic neurotransmission in Alzheimer's disease].Nihon Rinsho. 2011 Oct;69 Suppl 8:214-8. Nihon Rinsho. 2011. PMID: 22787784 Japanese. No abstract available.
-
[Glutamate and Alzheimer's disease].Rev Neurol. 2006 Apr 1-15;42(7):427-32. Rev Neurol. 2006. PMID: 16602060 Review. Spanish.
-
Glutamate in the mammalian CNS.Eur Arch Psychiatry Clin Neurosci. 1990;240(2):121-33. doi: 10.1007/BF02189982. Eur Arch Psychiatry Clin Neurosci. 1990. PMID: 1981150 Review.
Cited by
-
Opioid system and Alzheimer's disease.Neuromolecular Med. 2012 Jun;14(2):91-111. doi: 10.1007/s12017-012-8180-3. Epub 2012 Apr 22. Neuromolecular Med. 2012. PMID: 22527793 Review.
-
Characterization of histamine H3 receptors in Alzheimer's Disease brain and amyloid over-expressing TASTPM mice.Br J Pharmacol. 2009 May;157(1):130-8. doi: 10.1111/j.1476-5381.2008.00075.x. Epub 2009 Feb 16. Br J Pharmacol. 2009. PMID: 19222483 Free PMC article.
-
Mitragynine inhibits hippocampus neuroplasticity and its molecular mechanism.Pharmacol Rep. 2023 Dec;75(6):1488-1501. doi: 10.1007/s43440-023-00541-w. Epub 2023 Nov 4. Pharmacol Rep. 2023. PMID: 37924443 Free PMC article.
-
Pituitary Adenylate cyclase-activating polypeptide orchestrates neuronal regulation of the astrocytic glutamate-releasing mechanism system xc (.).J Neurochem. 2016 May;137(3):384-93. doi: 10.1111/jnc.13566. Epub 2016 Mar 1. J Neurochem. 2016. PMID: 26851652 Free PMC article.
-
Role of the glymphatic system and perivascular spaces as a potential biomarker for post-stroke epilepsy.Epilepsia Open. 2024 Feb;9(1):60-76. doi: 10.1002/epi4.12877. Epub 2023 Dec 14. Epilepsia Open. 2024. PMID: 38041607 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical